HUMPHREY RACHEL 4
4 · Pyxis Oncology, Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
HUMPHREY RACHEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-08-11+236,220→ 236,220 totalExercise: $2.91Exp: 2032-08-11→ Common Stock (236,220 underlying)
Footnotes (1)
- [F1]These stock options vest in three equal annual installments from the grant date, subject to the reporting person's continued service through the applicable vesting date.